Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Warminster, Pennsylvania
- Most recent report
- 8-K, filed Oct 22, 2026
- Incorporated
- N/A
- Filings on record
- 1,000+ filings
- On EDGAR
- CIK 1447028
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Smaller reporting company
Financials 8 of 165
News 8 of 313
Prospectuses and Registrations 8 of 28
- S-8 Registration statement for an employee plan Jun 5, 2026
- S-3 Shelf registration statement Nov 6, 2024
- S-8 Registration statement for an employee plan Aug 8, 2024
- S-8 Registration statement for an employee plan Aug 3, 2023
- S-8 Registration statement for an employee plan Aug 4, 2022
- 424B5 Prospectus supplement for an offering Mar 3, 2022
- S-3 Shelf registration statement Nov 4, 2021
- 424B5 Prospectus supplement for an offering Oct 8, 2021
Proxies 8 of 35
- DEFA14A Extra proxy material Apr 14, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 14, 2026
- DEFA14A Extra proxy material Apr 4, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 4, 2025
- DEFA14A Extra proxy material Apr 10, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 10, 2024
- DEFA14A Extra proxy material Apr 12, 2023
- DEF 14A Proxy statement for a shareholder vote Apr 12, 2023
Ownership 8 of 390
- SCHEDULE 13G/A Large holder reported a passive stake, amended Oct 27, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Oct 7, 2026
- 4 Insider reported a trade Oct 7, 2026
- 4 Insider reported a trade Oct 7, 2026
- 4 Insider reported a trade Oct 7, 2026
- 4 Insider reported a trade Oct 7, 2026
- SCHEDULE 13D/A Large holder reported an active stake, amended Oct 5, 2026
- 4 Insider reported a trade Oct 5, 2026
Other 8 of 69
Everything here comes from Arbutus Biopharma Corp's own filings on SEC EDGAR. The filing list is rechecked every hour.